0.7056
전일 마감가:
$0.74
열려 있는:
$0.72
하루 거래량:
271.08K
Relative Volume:
1.42
시가총액:
$31.59M
수익:
$80.28M
순이익/손실:
$-38.83M
주가수익비율:
-0.8483
EPS:
-0.8318
순현금흐름:
$-28.67M
1주 성능:
-11.91%
1개월 성능:
-13.32%
6개월 성능:
-38.11%
1년 성능:
-61.86%
Tela Bio Inc Stock (TELA) Company Profile
명칭
Tela Bio Inc
전화
484-320-2930
주소
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TELA
Tela Bio Inc
|
0.7056 | 31.59M | 80.28M | -38.83M | -28.67M | -0.8318 |
|
ABT
Abbott Laboratories
|
94.12 | 163.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
332.71 | 127.55B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
80.98 | 103.66B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.23 | 65.74B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
90.78 | 52.27B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 개시 | Lake Street | Buy |
| 2019-12-03 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | JMP Securities | Mkt Outperform |
| 2019-12-03 | 개시 | Jefferies | Buy |
| 2019-12-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Tela Bio Inc 주식(TELA)의 최신 뉴스
TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA) - TradingView
TELA Bio, Inc. Actuals & Estimates (BOATS:TELA) - TradingView
TELA Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
Price to sales forward of TELA Bio, Inc. – NASDAQ:TELA - TradingView
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
TELA Bio Inc (TELA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TELA Bio Inc (TELA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TELA Bio Inc (TELA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TELA Stock Price, Quote & Chart - ChartMill
TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TELA Bio Inc (TELA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TELA Bio Inc (TELA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TELA Bio Inc (TELA) Institutional Confidence - TradingKey
TELA Bio Inc (TELA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TELA Bio Inc. (TELA) Slides 5.7% as Shares Approach Critical Support at $0.82Volatility Breakout Picks - newsline.com
TELA Bio (TELA) grants director new RSUs and stock options - Stock Titan
TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options - Stock Titan
TELA Bio (NASDAQ: TELA) grants director new stock and options - Stock Titan
Joseph H. Capper joins TELA Bio (TELA) board and files initial insider report - Stock Titan
TELA Bio (TELA) director awarded 11,675 shares and options for 17,335 - Stock Titan
Director Guido J. Neels files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
TELA Bio : Initial Statement of Beneficial Ownership (Form 3) - marketscreener.com
TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership - Stock Titan
TELA Bio (TELA) director Paul Thomas receives RSU and option grants - Stock Titan
Director Guy P. Nohra files initial Form 3 for TELA Bio (NASDAQ: TELA) - Stock Titan
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Shareholders Expand Equity Incentive Plan Authorization - TipRanks
TELA Bio (NASDAQ: TELA) OKs 3.5M-share incentive plan boost - Stock Titan
TELA Bio Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesRevenue Recognition Risk - newsline.com
EW Healthcare Partners Fund 2-UGP Secures Board Seat at TELA Bio with 17.23% Stake - TradingView
EW Healthcare funds report 7.7M TELA Bio (TELA) shares and board seat - Stock Titan
TELA Bio Inc Annual Shareholders Meeting Transcript - GuruFocus
TELA Q1 2026 Earnings: EPS Miss Sends Stock Slightly LowerRevenue Inflection Point - newsline.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - MSN
TELA Bio | 8-K: Current report - Moomoo
TELA Bio Expands Europe Sales as U.S. Growth Slows - MyChesCo
TELA Bio Inc. (TELA) Edges Lower, Tests Key Support After 2.7% DeclineUser Trade Ideas - Newser
Tela Bio Eyes Second-Half Ramp After Mixed Quarter - TipRanks
TELA Bio (TELA) Q1 2026 Results Miss Estimates — EPS $-0.21 vs $-0.19Retail Earnings Report - Newser
TELA Bio Healthcare Story Faces New Market Scrutiny - Kalkine Media
TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake - Stock Titan
Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report - simplywall.st
Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25 - Yahoo Finance
About Us | Oil & Gas JournalTELA Bio, Inc.Common stock (Nasdaq:TELA) Stock Quote - FinancialContent
Becton Dickinson stock (US0718131099): Antitrust case survives dismissal - AD HOC NEWS
TELA Bio, Inc. (TELA) reports Q1 loss, beats revenue estimates - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail
Tela Bio Earnings Call Balances Momentum and Risk - TipRanks
Tela Bio Inc (TELA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):